Title : Shikonin potentiates paclitaxel antitumor efficacy in esophageal cancer cells via the apoptotic pathway.

Pub. Date : 2019 Sep

PMID : 31452796






1 Functional Relationships(s)
Download
Sentence
Compound Name
Protein Name
Organism
1 In summary, shikonin can sensitize esophageal cancer cells to paclitaxel-treatment by promoting cell mitotic arrest and reinforcing the susceptibility of esophageal cancer cells to apoptosis induced by paclitaxel, which is potentially associated with altered levels of Bcl-2 and p53. Paclitaxel tumor protein p53 Homo sapiens